Why the study?
Do treatments directed at neurally mediated hypotension improve symptoms in patients with chronic fatigue syndrome?
Do treatments directed at neurally mediated hypotension improve symptoms in patients with chronic fatigue syndrome?
Answers are grounded in this paper and cite their sources.
Clinical evidence suggests an association between neurally mediated hypotension and chronic fatigue syndrome, with ongoing trials evaluating targeted treatments.
A substantial body of clinical evidence now supports an association between various forms of hypotension and both idiopathic chronic fatigue and the chronic fatigue syndrome (CFS). Patients with CFS have a high prevalence of neurally mediated hypotension, and open treatment of this autonomic dysfunction has been associated with improvements in CFS symptoms. Randomized trials are now in progress to evaluate the efficacy of treatments directed at neurally mediated hypotension in those with CFS patients, and the results of these trials should help guide more basic inquiries into the mechanisms of orthostatic intolerance in affected individuals.
No takes yet. Share an insight, caveat, or question.
Rowe et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: